AWMDMG
ASPX

Austin W. Marxe & David M. Greenhouse’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-79,700
Closed -$2.45M – 150
2014
Q1 		$2.45M Buy
+79,700
New +$2.14M 0.27% 85

Other funds holding ASPX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ASPX Position: Q2 2014 in Review

Austin W. Marxe & David M. Greenhouse sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2014, closing a stake of 79,700 shares — an estimated $2.45M sold.

Austin W. Marxe & David M. Greenhouse first reported a position in ASPX in Q1 2014 and held it in 1 quarter. The position peaked at $2.45M in Q1 2014. 61 funds tracked by Wall St. Rank hold ASPX as of Q2 2014.

  • Austin W. Marxe & David M. Greenhouse reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • Austin W. Marxe & David M. Greenhouse sold 79,700 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $2.45M.
  • Austin W. Marxe & David M. Greenhouse first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • Austin W. Marxe & David M. Greenhouse's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.45M in Q1 2014.
  • 61 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q2 2014, filed 8 Aug 2014.